Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...

The nanoparticles significantly reduced the ... The researchers plan to further refine As@LNPs by studying their pharmacokinetics and long-term safety in larger animal models.

Nanoparticle curcumin called ‘Theracurmin ... and membrane permeability and improving its pharmacokinetics, pharmacodynamics, and biodistribution. Effects of curcumin nanoformulations on ...

Lipoprotein-based nanoparticles with excellent biocompatibility, favorable pharmacokinetics, nonimmunogenicity, suitably small size (<30 nm) and active targeting features demonstrate great ...

Nanoparticle albumin-bound paclitaxel (nab ... which leads to decrease plasma clearance, pseudo-nonlinear pharmacokinetics and decreased free paclitaxel. This may lead to prolonged exposure ...